Archive for October 9th, 2009

Acorda Options Worth Second Look (ACOR)

Acorda Therapeutics, Inc. (NASDAQ: ACOR) was covered already this morning for its significant price-volume alert.  Including teh after-hours session at 4:45 PM EST we saw some 14.54 million shares trade and the stock closed out down 21% at $17.52.  This volume is impressive even if the price drop is not, but there was also a [...]

Options Alert in Applied Materials (AMAT)

Applied Materials Inc. (NASDAQ: AMAT) has only just now crossed its average daily volume at 3:40 PM EST.  We have seen 21.9 million shares trade versus and average daily volume of 21.8 million shares of stock.  The gain is 0.7% at $13.19, so that sounds only normal.  BUt Joe Kunkle of sent an alert [...]

Traders Keep Nibbling on Sequenom (SQNM)

Sequenom Inc. (NASDAQ: SQNM) is surging higher again today.  At 10:35 AM EST we have not seen an exponential volume alert as the volume is now just over 7 million shares versus 9.4 million on average.  But the stock is up another 9.8% at $3.67.  This one has risen since meeting with the SEC and [...]

Sunrise Senior Hits Exponential Volume Alert in 1 Hour (SRZ)

Sunrise Senior Living Inc. (NYSE: SRZ), which should arguably be called Sunset Senior Living, is seeing an exponential volume surge this morning.  The reason for the move is that Sunrise entered into an agreement to sell 21 communities for about $204 to Brookdale.  Sunrise shares are up 25% at $4.13 today, and its market cap [...]

AVANIR Surging on Data (AVNR)

AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) is surging on strong volume this morning.  The company announced additional detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ in the treatment of pseudobulbar affect among patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS). Zenvia met the [...]

Volume Spikes Up in Taiwan Semi (TSM)

Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE: TSM) announced that its September unconsolidated sales fell by about 3% to NT$28.02 billion and consolidated sales were down 3% to NT$28.94 billion.  This actually meets its sales plabn though and shares are up marginally.  At 8:35 AM EST we have the NYSE ADRs trading up 0.3% at $9.95.  [...]

Infosys Beats Earnings Estimates… Not Enough? (INFY)

Infosys Technologies Limited (NASDAQ: INFY) beat earnings this morning, although the stock is lower as investors wanted to see more.  The Indian IT-outsourcing shop posted $0.56 EPS pn $1.15 billion in revenues vs. Thomson Reuters consensus of $0.50 and $1.12 billion.  It also raised FY10 targets to $2.09 to $2.10 EPS and $4.6 to $4.62 [...]

Savient Rises on Secondary Pricing (SVNT)

Savient Pharmaceuticals Inc. (NASDAQ: SVNT) is seeing a lot of volume trade based on a seondary offering.  The company priced a 4.4 million share secondary offering of common stock, up from 4 million shares originally, at $13.29 per share in a sale through J.P. Morgan and Wedbush Morgan.  Savient closed at $13.29 yesterday, and shares [...]

Acorda Down Over 10% Ahead of FDA (ACOR)

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is getting hit hard this morning ahead of an expected FDA decision to make public the background material over Acorda’s Fampridine on or before October 12.  Shares are dowhn 11% at $19.86 on about 400,000 shares as of 8:20 AM EST.  Average volume is 450,000 shares and the 52-week trading [...]

Spectrum Slapped by FDA (SPPI)

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is getting its wings clipped this morning.  The company received a complete response letter from FDA for FUSILEV in advanced metastatic colorectal cancer.  The response noted that it did not demonstrate that FUSILEV is non-inferior to leucovorin and recommended that it meet with them to discuss options for continuing to [...]